Genocea Biosciences (GNCA) Tops Q2 EPS by 8c

Genocea Biosciences (NASDAQ: GNCA) reported Q2 EPS of ($0.43), $0.08 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $115 thousand versus the consensus estimate of $50 thousand.

For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
• Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results